Oruka Therapeutics (ORKA) Retained Earnings (2010 - 2026)
Oruka Therapeutics' quarterly Retained Earnings came in at -$480000.0 in Q1 2026, down 7900.0% year-on-year from $6153.8 in Q1 2025, and up 99.75% quarter-over-quarter from -$189.2 million in Q4 2025.
Oruka Therapeutics has reported Retained Earnings for 17 years, with the latest figure at -$480000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 7900.0% year-over-year to -$480000.0; the trailing twelve-month figure through Mar 2026 stood at -$480000.0 (down 7900.0% YoY), and the FY2025 full-year result was -$189.2 million, down 125.93% from the prior year.
- Retained Earnings for Q1 2026 stood at -$480000.0, up from -$189.2 million in the prior quarter.
- The five-year high for Retained Earnings was -$6000.0 in Q1 2025, with the low at -$193.4 million in Q2 2024.
- Average Retained Earnings over 5 years is -$137.9 million, with a median of -$182.2 million recorded in 2022.
- Year-over-year, Retained Earnings surged 100.0% in 2025 and sank 7900.0% in 2026.
- Tracing ORKA's Retained Earnings over 5 years: stood at -$183.4 million in 2022, then decreased by 2.91% to -$188.7 million in 2023, then jumped by 55.64% to -$83.7 million in 2024, then plunged by 125.93% to -$189.2 million in 2025, then jumped by 99.75% to -$480000.0 in 2026.
- The last three Retained Earnings figures came in at -$480000.0 (Q1 2026), -$189.2 million (Q4 2025), and -$159.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | -480,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -480,000.00 |
| Dec 31, 2025 | -189.16 Mn |
| Sep 30, 2025 | -159.57 Mn |
| Jun 30, 2025 | -27,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | -83.72 Mn |
| Sep 30, 2024 | -57.94 Mn |
| Jun 30, 2024 | -193.43 Mn |
| Mar 31, 2024 | -190.75 Mn |
| Dec 31, 2023 | -188.74 Mn |
| Sep 30, 2023 | -187.65 Mn |
| Jun 30, 2023 | -186.23 Mn |
| Mar 31, 2023 | -184.75 Mn |
| Dec 31, 2022 | -183.40 Mn |
| Sep 30, 2022 | -182.23 Mn |
| Jun 30, 2022 | -179.90 Mn |
| Mar 31, 2022 | -176.75 Mn |
| Dec 31, 2021 | -173.48 Mn |
| Sep 30, 2021 | -167.80 Mn |
| Jun 30, 2021 | -163.09 Mn |
| Mar 31, 2021 | -158.25 Mn |
| Dec 31, 2020 | -154.15 Mn |
| Sep 30, 2020 | -149.03 Mn |
| Jun 30, 2020 | -147.04 Mn |
| Mar 31, 2020 | -145.74 Mn |
| Dec 31, 2019 | -144.42 Mn |
| Sep 30, 2019 | -143.19 Mn |
| Jun 30, 2019 | -142.03 Mn |
| Mar 31, 2019 | -140.60 Mn |
| Dec 31, 2018 | -138.93 Mn |
| Sep 30, 2018 | -137.45 Mn |
| Jun 30, 2018 | -135.85 Mn |
| Mar 31, 2018 | -133.74 Mn |
| Dec 31, 2017 | -131.00 Mn |
| Sep 30, 2017 | -3,000.00 |
| Jun 30, 2017 | -5,000.00 |
| Mar 31, 2017 | -116.85 Mn |
| Dec 31, 2016 | -112.51 Mn |
| Sep 30, 2016 | -6,000.00 |
| Jun 30, 2016 | 13,000.00 |
| Mar 31, 2016 | -99.71 Mn |
| Dec 31, 2015 | -96.07 Mn |
| Sep 30, 2015 | -92.90 Mn |
| Jun 30, 2015 | -90.09 Mn |
| Mar 31, 2015 | -87.37 Mn |
| Dec 31, 2014 | -84.62 Mn |
| Sep 30, 2014 | -82.01 Mn |
| Jun 30, 2014 | -79.73 Mn |
| Mar 31, 2014 | -77.32 Mn |
| Dec 31, 2013 | -74.93 Mn |
| Sep 30, 2013 | -71.99 Mn |
| Jun 30, 2013 | -70.26 Mn |
| Mar 31, 2013 | -69.07 Mn |
| Dec 31, 2012 | -67.99 Mn |
| Sep 30, 2012 | -67.15 Mn |
| Jun 30, 2012 | -66.23 Mn |
| Mar 31, 2012 | -65.08 Mn |
| Dec 31, 2011 | -63.67 Mn |
| Sep 30, 2011 | -62.04 Mn |
| Jun 30, 2011 | -60.22 Mn |
| Dec 31, 2010 | -58.31 Mn |